UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | June 16, 2021 4:00 P.M. |
Form: | S-4 | ||||||
|
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | June 16, 2021 4:00 P.M. |
Form: | S-4 | ||||||
|
Save time and jump to the most important pieces.
SC 13G/A - Ensysce Biosciences, Inc. (0001716947) (Subject)
SC 13D - Ensysce Biosciences, Inc. (0001716947) (Subject)
SC 13G/A - Leisure Acquisition Corp. (0001716947) (Subject)
HOUSTON, April 02, 2024 (GLOBE NEWSWIRE) -- MRC Global Inc. (NYSE:MRC) ("MRC Global" or the "Company"), the leading global distributor of pipe, valves and fittings (PVF) and other infrastructure products and services to diversified gas utility, energy and industrial end-markets, today announced that Daniel Silvers has been appointed to the Company's Board of Directors, effective immediately. Mr. Silvers will serve on the Board's Compensation and Environmental, Social, Governance and Enterprise Risk Committees. Mr. Silvers' appointment is made in conjunction with a cooperation agreement that the Company has reached with Engine Capital, L.P. ("Engine"). Robert Wood, MRC Global'
8-K - Ensysce Biosciences, Inc. (0001716947) (Filer)
8-K - Ensysce Biosciences, Inc. (0001716947) (Filer)
8-K - Ensysce Biosciences, Inc. (0001716947) (Filer)
4 - Ensysce Biosciences, Inc. (0001716947) (Issuer)
4 - Ensysce Biosciences, Inc. (0001716947) (Issuer)
4 - Ensysce Biosciences, Inc. (0001716947) (Issuer)
HOUSTON, April 02, 2024 (GLOBE NEWSWIRE) -- MRC Global Inc. (NYSE:MRC) ("MRC Global" or the "Company"), the leading global distributor of pipe, valves and fittings (PVF) and other infrastructure products and services to diversified gas utility, energy and industrial end-markets, today announced that Daniel Silvers has been appointed to the Company's Board of Directors, effective immediately. Mr. Silvers will serve on the Board's Compensation and Environmental, Social, Governance and Enterprise Risk Committees. Mr. Silvers' appointment is made in conjunction with a cooperation agreement that the Company has reached with Engine Capital, L.P. ("Engine"). Robert Wood, MRC Global'
Believes it is Critical to Add Directors with an Investor Mindset, and Capital Allocation and Financial Markets Experience Underscores Engine's Repeated Attempts to Avoid an Election Contest, Including by its Willingness to Settle for Reduced Board Representation Engine Capital, L.P. (together with its affiliates, "Engine"), a significant shareholder of MRC Global Inc. (NYSE:MRC) ("MRC" or the "Company") and the owner of nearly 4.3% of the Company's outstanding common stock, today announced it has filed a preliminary proxy statement with the U.S. Securities and Exchange Commission in connection with its nomination of two highly qualified candidates for election to the Company's Board of
SAN DIEGO, June 30, 2021 (GLOBE NEWSWIRE) -- Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (OTC:LACQ, LACQW))) today announced that, in connection with the closing of its previously announced merger with Leisure Acquisition Corp. ("LACQ"), the combined company, Ensysce Biosciences, Inc., will commence trading its common stock and warrants under the ticker symbols "LACQ" and "LACQW," respectively, on the OTC Market on July 1, 2021. As previously announced, the merger was approved by LACQ's shareholders on June 28, 2021 and closed on June 30, 2021. The Company will announce further trading information at a later time. Forward Looking Statements This press release contains certain